TurboVets is fully live. For support, please submit tickets in app.
Sign In to TurboVets
Your Data is Protected. Never Sold. Never Used for Profit.
Read our FAQ
6329
§ 4.88b Schedule of ratings—infectious diseases, immune disorders and nutritional deficiencies.

Hemorrhagic fevers

Viral infections causing fever and bleeding, including dengue, yellow fever, and Ebola.

What the rating means

Hemorrhagic fevers — including dengue, yellow fever, and similar illnesses — are rated under the General Rating Formula for Infectious Diseases. While the disease is active, the rating is 100 percent. Once the active disease has resolved, the infection itself is rated at 0 percent. Any lasting health problems caused by the infection are then rated separately under the body system they affect. For example, damage to the liver, kidneys, or central nervous system would each be evaluated under the rules that apply to those organs or systems. This means your overall disability rating after recovery depends entirely on what residual conditions remain and how severely they affect you.

Evidence that helps

During active disease, medical records confirming the diagnosis and showing the illness is ongoing are the core evidence. After the disease resolves, the focus shifts to records documenting any lasting damage. Lab results showing reduced kidney or liver function, imaging of affected organs, neurology evaluations, or specialist findings that tie a condition directly to the hemorrhagic fever infection are all relevant. Records from the time of the acute illness help establish that a later condition is a residual of the infection rather than an unrelated problem. Statements from you or people who know you describing how lingering symptoms affect your work, daily tasks, or activities also help show the severity of any residual condition under the body system being evaluated.

Secondary conditions

Conditions that are often caused or made worse by this one. If you have any of these, they may be claimable as secondary service connection.